...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Identifying Rational Candidates for Immunotherapy Targeting PD-1/PD-L1 in Cervical Cancer
【24h】

Identifying Rational Candidates for Immunotherapy Targeting PD-1/PD-L1 in Cervical Cancer

机译:鉴定宫颈癌中的免疫疗法的理性候选者靶向PD-1 / PD-L1

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aim: To investigate the abundance of programmed death-ligand 1 (PD-L1) expression and identify rational candidates for anti-PD-1/PD-L1 immunotherapies in cervical cancer. Patients and Methods: In 27 patients with FIGO stage IB1-IIA cervical cancer, paraffin-embedded tumors were immunohistochemically stained with PD-L1 antibody. The correlation of tumoral PD-L1 expression with clinicopathological factors and survival outcomes were evaluated. Results: Overall, PD-L1 expression was primarily detected in 12 (44.4%) patients. All tumors with PD-L1 expression were squamous cell carcinomas (SqCC). In subgroup analysis of SqCC, higher PD-L1 expression was associated with low preoperative serum SqCC antigen level (p= 0.030) and no parametrial invasion (p= 0.048). The 5-year progression-free survival (83.3% vs. 50.0%. p= 0.136) and overall survival rates (90.9% vs. 83.3%, p= 0.615) were superior in patients with PD-L1 expression that in those without PD-L1 expression; however, neither was significant. Conclusion: Patients with SqCC and favorable clinicopathological factors could be candidates for anti-PD-1/PD-L1 immunotherapy in cervical cancer.
机译:背景/目的:研究编程死亡 - 配体1(PD-L1)表达的丰度,并鉴定宫颈癌中的抗PD-1 / PD-L1免疫治疗的理性候选者。患者和方法:在27例Figo阶段IB1-Iia宫颈癌患者中,用PD-L1抗体免疫染色石蜡包埋的肿瘤。评估了肿瘤PD-L1表达与临床病理因子和存活结果的相关性。结果:总体上,PD-L1表达主要在12名(44.4%)患者中检测。所有具有PD-L1表达的肿瘤都是鳞状细胞癌(SQCC)。在SQCC的亚组分析中,较高的PD-L1表达与低术前血清SQCC抗原水平有关(P = 0.030)并且没有参数侵袭(P = 0.048)。 5年的进展生存率(83.3%对50.0%。P = 0.136)和总存活率(90.9%与83.3%,p = 0.615)在没有PD的PD-L1表达的患者中优越-l1表达;但是,两者都没有重要。结论:SQCC和有利的临床病理因子患者可以是宫颈癌抗PD-1 / PD-L1免疫疗法的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号